Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: A blinded, case-control study

The Lancet

Volumn 383, Issue 9912, 2014, Pages 138-145

  Traboulsee, Anthony L ^a   Knox, Katherine B ^b,c   Machan, Lindsay ^b   Zhao, Yinshan ^a   Yee, Irene ^a   Rauscher, Alexander ^b   Klass, Darren ^b   Szkup, Peter ^c   Otani, Robert ^c   Kopriva, David ^d   Lala, Shanti ^d   Li, David K ^b   Sadovnick, Dessa ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Department of Medical Genetics ^*  (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AZYGOS VEIN; CANADA; CASE CONTROL STUDY; CATHETER; CATHETER VENOGRAPHY; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER FLOWMETRY; EXTRACRANIAL VENOUS NARROWING; FEMALE; HUMAN; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHLEBOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIBLING; SINGLE BLIND PROCEDURE; VEIN OCCLUSION; YOUNG ADULT;

EID: 84892364408     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61747-X     Document Type: Article

References (34)

1. Multiple Sclerosis International Federation. What is MS? http://www.msif.org/about-ms/what-is-ms-1.aspx (accessed June 3, 2013).
2. Fog T. On the vessel-plaque relations in brain in multiple sclerosis. Acta Neurol Scand 1963; 39: 258-62.
3. Juurlink BHJ. The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infi ltration are readily upregulated? Med Hypotheses 1998; 51: 299-303.
4. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insuffi ciency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 392-99.
5. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insuffi ciency. J Vasc Surg 2009; 50: 1348-58.
6. W5's ground-breaking investigation of CCSVI. http://www.ctvnews. ca/w5/w5-s-investigation-of-ccsvi (accessed June 3, 2013).
7. Ghezzi A, Annovazzi P, Amato MP, et al, MS Study Group-Italian Society of Neurology. Adverse events after endovascular treatment of chronic cerebro-spinal venous insuffi ciency (CCSVI) in patients with multiple sclerosis. Mult Scler 2013; 19: 961-63.
8. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010; 68: 173-83.
9. Vedantham S, Benenati JF, Kundu S, et al, Society of Interventional Radiology, and the Canadian Interventional Radiology Association. Interventional endovascular management of chronic cerebrospinal venous insuffi ciency in patients with multiple sclerosis: a position statement by the Society of Interventional Radiology, endorsed by the Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010; 21: 1335-37.
10. Multiple Sclerosis International Feteration statement on CCSVI. http://www.msif.org/global-ms-research/msif-statement-on-ccsvi. aspx (accessed June 3, 2013).
11. FDA safety communication: chronic cerebrospinal venous insuffi ciency treatment in multiple sclerosis patients. http://www. fda.gov/MedicalDevices/ Safety/AlertsandNotices/ucm303318 (accessed June 3, 2013).
12. IPG420. Percutaneous venoplasty for chronic cerebrospinal venous insuffi ciency for multiple sclerosis. http://publications.nice.org.uk/percutaneous- venoplasty-for-chronic-cerebrospinal-venousinsuffi ciency-for-multiple- sclerosis-ipg420 (accessed June 3, 2013).
13. Valdueza JM, Doepp F, Schreiber SJ, et al. What went wrong? The fl awed concept of cerebrospinal venous insuffi ciency. J Cereb Blood Flow Metab 2013; 33: 657-68.
14. Centonze D, Floris R, Stefanini M, et al. Proposed chronic cerebrospinal venous insuffi ciency criteria do not predict multiple sclerosis risk or severity. Ann Neurol 2011; 70: 51-58.
15. Mayer CA, Pfeilschifter W, Lorenz MW, et al. The perfect crime? CCSVI not leaving a trace in MS. J Neurol Neurosurg Psychiatry 2011; 82: 436-40.
16. Tsivgoulis G, Mantatzis M, Bogiatzi C, et al. Extracranial venous hemodynamics in multiple sclerosis: a case-control study. Neurology 2011; 77: 1241-45.
17. Wattjes MP, van Oosten BW, de Graaf WL, et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and fl ow-quantifi cation study. J Neurol Neurosurg Psychiatry 2011; 82: 429-35.
18. Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fl uid fl ow in multiple sclerosis: a case-control study. Ann Neurol 2010; 68: 255-59.
19. Doepp F, Wurfel JT, Pfueller CF, et al. Venous drainage in multiple sclerosis: a combined MRI and ultrasound study. Neurology 2011; 77: 1745-51.
20. Gisolf J, van Lieshout JJ, van Heusden K, Pott F, Stok WJ, Karemaker JM. Human cerebral venous outfl ow pathway depends on posture and central venous pressure. J Physiol 2004; 560: 317-27.
21. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3: 104-10.
22. Sadovnick AD, Yee IM, Guimond C, Reis J, Dyment DA, Ebers GC. Age of onset in concordant twins and other relative pairs with multiple sclerosis. Am J Epidemiol 2009; 170: 289-96.
23. DeLuca GC, Ramagopalan SV, Herrera BM, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci USA 2007; 104: 20896-901.
24. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC, the Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003; 100: 12877-82.
25. Ebers GC, Sadovnick AD, Risch NJ, the Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995; 377: 150-51.
26. Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N. Parent-of-origin eff ect in multiple sclerosis: observations in half-siblings. Lancet 2004; 363: 1773-74.
27. Dyment DA, Yee IM, Ebers GC, Sadovnick AD, the Canadian Collaborative Study Group. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006; 77: 258-59.
28. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
30. Scalise F, Farina M, Manfredi M, Auguadro C, Novelli E. Assessment of jugular endovascular malformations in chronic cerebrospinal venous insuffi ciency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound. Phlebology 2013; published online May 3. DOI:10.1258/phleb.2012.012079.
31. Simka M, Ludyga T, Latacz P, Kazibudzki M. Diagnostic accuracy of current sonographic criteria for the detection of outfl ow abnormalities in the internal jugular veins. Phlebology 2013; 28: 285-92.
32. Brod SA, Kramer LA, Cohen AM, et al. Chronic cerebrospinal venous insuffi ciency: masked multimodal imaging assessment. Mult Scler 2013; published online July 16. DOI:10.1177/1352458513494493.
33. Zivadinov R, Galeotti R, Hojnacki D, et al. Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. AJNR Am J Neuroradiol 2011; 32: 938-46.
34. Laupacis A, Lillie E, Dueck A, et al. Association between chronic cerebrospinal venous insuffi ciency and multiple sclerosis: a meta-Analysis. CMAJ 2011; 183: E1203-12.